Minimally Invasive Surgery Cuts Complications and Mortality in Pancreatic Cancer Patients

Minimally invasive distal pancreatectomy (MIDP) markedly reduces hospital stays, infections, and 90-day mortality compared to open distal pancreatectomy (ODP) in pancreatic ductal adenocarcinoma patients. Analyzing data from 20 studies involving 9,339 patients, MIDP also leads to significantly lower blood loss and transfusions. Despite showing better clinical outcomes, further randomized clinical trials are necessary to solidify these findings and reconsider current surgical guidelines.